This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the sideeffects, it’s important for healthcareproviders to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. For too long, the administrative side of healthcare has lagged behind its clinical advancements. Its simple: Digital patient intake forms. What is Digital Patient Intake?
From enhancing diagnostic accuracy, to leveraging predictive analytics and developing personalized care plans, to supporting decision making and enhancing patient engagement, the use of AI in healthcare has many promising applications. This, in turn, strengthens market positioning, fosters patient trust, and helps to drive growth.
Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). At the same time, patient portals have always been considered one of the most efficient tools for patient engagement. Explaining Medication Action.
There isn’t one method to get people exercising; it will take an approach for every healthcareprovider to communicate the importance of exercise. Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise.
However, patient uptake hasn’t matched rising market competition. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. These low adoption rates highlight the need for more migraine-drug awareness and suggest that pharma marketers should explore new strategies to boost patient uptake.
At Clalit, which is the second largest healthcareprovider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a healthcare system. What is patient centricity and why is it an important consideration in drug development?
For pharma, these ads are tailored to showcase treatments, educate healthcare professionals, or increase patient awareness. Patients and healthcareproviders need timely, accurate information about medications. Social media : Facebook and LinkedIn offer tailored targeting for healthcare professionals and patients.
AUSTEDO XR helps treat tardive dyskinesia (TD), a sideeffect of taking medications for mental illness. To help patients and HCPs recognize TD, our team partnered with Teva on two new TV spots focusing on two different journeys of characters who have TD. It’s estimated that some 85% of TD cases go undiagnosed.
1 Yet, most patients haven’t tried prescription therapies, a discovery Phreesia Life Sciences made after surveying 6,780 adults age 18 and older who previously had been diagnosed with or treated for constipation as they checked in for their doctors’ appointments. Address Patients’ Quality of Life. Why the disconnect?
Understanding Your Audience: Different audiencespatients, healthcare professionals, or payersrequire tailored messages. For instance, while patients prioritize benefits and sideeffects, healthcareproviders look for clinical evidence and efficacy. How can you ensure your strategy stands out?
Cancer-support programs provide vital assistance to patients and their caregivers as they face one of the toughest times of their lives. Yet while patients are interested in these programs, new survey data suggests they aren’t taking advantage of them. We’re committed to serving the entire patient community.”
With the assistance of AI tools, pharma marketers can develop personalized sales messages and educational content, improving their engagement with healthcareproviders and equipping them to deliver better patient care. With AI-powered chatbots and services, patients can access the information they need more efficiently.
The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases. The aim of the programme is to expedite the development, assessment and review of medical devices in order to provide timely access to patients and healthcareproviders.
Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, sideeffects do happen.
The healthcare industry – along with the rest of the modern world – is witnessing a transformative shift with the integration of artificial intelligence (AI), reshaping the way providers interact with and care for patients.
In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. Ensuring patient access. Retaining business begins with patient access. Preventing patient drop-off. in 1979 to 2.8%in
In the pharmaceutical industry, patient support programs (PSPs) and brand teams often work in silos, despite their shared goal of helping patients achieve a certain health outcome. Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcareproviders (HCPs).
These intelligent digital assistants are revolutionizing how healthcareproviders interact with patients, boosting engagement, streamlining support services, and enhancing patient experiences. They can also provide appointment reminders, reducing the chance of no-shows.
At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed. Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients. The rise of immunotherapies.
The nonprofit Physicians for Patient Protection also raised a similar point that pharmacists who may be unfamiliar with a patient’s medical history can pose the risk of significant negative health outcomes if Paxlovid is incorrectly prescribed. This is where pharmacists can make a difference, he notes.
This includes in-depth knowledge of the science behind the products, as well as their indications, contraindications, and potential sideeffects. This helps me to be able to answer any question or concern a healthcareprovider may have about the product. But product knowledge is not the only important aspect of my job.
Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential sideeffects of different drugs. However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information.
The medical sales industry plays a crucial role in connecting healthcareproviders with innovative medical products and technologies. While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Protecting patient confidentiality is paramount.
Adherence to medications – defined as the extent to which patients take medications as prescribed by their healthcareproviders – can be a significant clinical challenge. In developing countries, rates are even lower, with many patients showing difficulty in following treatment recommendations.
Customer loyalty in action: Reducing hospital readmissions with proactive care Let’s look at a fictional healthcareprovider, Great Health, Inc., which faced a high rate of hospital readmissions following patient discharges. This included details about a patient’s diagnosis, treatment plan, and existing health conditions.
Healthcareproviders are busy people, and they don't have time to listen to a sales pitch unless it's relevant to their needs. To be successful, you need to be able to convince them that your product is the best solution for their patients. One of the most critical situations where persuasion is needed is when facing objections.
The healthcare landscape is vast and varied, with each stakeholder bringing their unique viewpoint to the table. Whether you're a hospital administrator crunching numbers, a doctor ensuring the best patient outcomes, or a patient seeking the best care, "value" can look quite different. For them, it's all about patient outcomes.
The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution.
UK-based George Medicines is running a phase 3 trial of GMRx2 – a low-dose formulation of established blood pressure drugs telmisartan, amlodipine, and indapamide – involving 1,500 patients across seven countries.
My client, Dr. Stevens, was already seated, reviewing some patient files. Doctor, if you don't mind me asking, what are some of the challenges you're currently facing with your patients on chronic pain management?" Many patients either forget to take their medication or stop altogether because of sideeffects." "I
Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.
During my pharmacology class, I learned that there are no safe drugs, only safe patients. This highlights the importance of taking an individualized approach to medicine and considering a patient's unique medical history, current health status, and other relevant factors when prescribing medication.
From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. The pharmaceutical industry has numerous use cases for AI.
According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines. As the data landscape evolves, what is the most exciting innovation in clinical data management.
Table of Contents Sr# Headings 1 Introduction: The Importance of Marketing in Pharma 2 Digital Strategies Redefining Pharma Marketing 3 Building Trust Through Patient-Centric Campaigns 4 Navigating Compliance While Innovating Introduction: The Importance of Marketing in Pharma Marketing in pharma has never been more critical.
In essence, pharma sales is about connecting healthcareproviders with the medications and treatments they need for their patients. There's a sense of accomplishment in knowing that my work contributes to healthcare and patient wellbeing. Diving into the Heart of Pharma Sales Let me share more.
Traditionally, when pharma marketers and their strategy, creative, and media agencies develop marketing plans, investment recommendations tend to focus on HCPs, patients, and managed care. On the HCP side, marketers tend to allocate the bulk of their investment on medical doctors as, historically, they have been the primary prescribers.
We were drilled on the science behind our medications, their benefits, potential sideeffects, and the competitive landscape. We were the bridge between the pharmaceutical companies and the healthcareproviders, and our credibility depended on our knowledge and communication skills.
Med reps provide information about their products, explain their benefits and sideeffects, and try to convince doctors and other healthcareproviders to prescribe or use them. There's a concern that the push to increase sales might, at times, overshadow the genuine need or suitability of a product for a patient.
However, due to conjugation instability and unfavorable safety profiles of currently available ADCs, we can still do more to ensure ADCs are more broadly available and amenable options for the patients who need them. Cellectis is pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients.
This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Businesses looking to enter this market must differentiate their offerings to attract and retain patients. This can be done through blog posts, webinars, and informational videos.
Pharma advertising isn’t just about promoting products—it’s about reaching patients, caregivers, and healthcare professionals with valuable, meaningful information. With digital channels, evolving regulations, and changing patient expectations, creating an impactful advertising strategy can feel complex.
Engaging with healthcare professionals and patients through educational initiatives and open dialogue helps to demystify complex information and foster a sense of reliability between the two. PM360 asked a few specialists to share their intake on building trust equity with patients in the industry.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content